Accumulating evidence suggests that gut microbial dysbiosis is implicated in colorectal
cancer (CRC) initiation and progression through interaction with host immune system. Given …

Background & Aims Fecal tests currently used for colorectal cancer (CRC) screening show
limited accuracy in detecting early tumors or precancerous lesions. In this respect, we …

In the current era of precision oncology, it is widely acknowledged that CRC is a
heterogeneous disease entity. Tumor location (right-or left-sided colon cancer or rectal …

Simple Summary Studies of gut microbiome in patients with colorectal cancer (CRC) have
shown strong alterations of its community structure. Identification of the early signs of …

Tumor microenvironment has recently been ascribed a new hallmark—the polymorphic
microbiome. Accumulating evidence regarding the tissue specific territories of tumor …

An increasing amount of evidence suggests the emerging role of the gut microbiota in the
development of colorectal cancer (CRC). This study aimed to elucidate the architecture of …

Colorectal cancer (CRC) is influenced by perturbations in the colonic microbiota,
characterized by an imbalance favoring pathogenic bacteria over beneficial ones. This …

Background Colon microbiome composition contributes to the pathogenesis of colorectal
cancer (CRC) and prognosis. We analyzed 16S rRNA sequencing data from tumor samples …

Motivation In the field of microbiome analysis, there exist various statistical methods that
have been developed for identifying differentially expressed features, that account for the …

Colorectal cancer (CRC) is the third most common cancer and the second leading cause of
cancerrelated deaths worldwide. Recent advancements in high-throughput technologies …